Page last updated: 2024-10-23

bromhexine and Cancer of Head

bromhexine has been researched along with Cancer of Head in 1 studies

Bromhexine: A mucolytic agent used in the treatment of respiratory disorders associated with viscid or excessive mucus. (From Martindale, The Extra Pharmacopoeia, 30th ed, p744)
bromhexine : A substituted aniline that is 2,4-dibromoaniline which is substituted at position 6 by a [cyclohexyl(methyl)amino]methyl group. It is used (as the monohydrochloride salt) as a mucolytic for the treatment of respiratory disorders associated with productive cough (i.e. a cough characterised by the production of sputum).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Spector, ME1
Gallagher, KK1
Light, E1
Ibrahim, M1
Chanowski, EJ1
Moyer, JS1
Prince, ME1
Wolf, GT1
Bradford, CR1
Cordell, K1
McHugh, JB1
Carey, T1
Worden, FP1
Eisbruch, A1
Chepeha, DB1

Other Studies

1 other study available for bromhexine and Cancer of Head

ArticleYear
Matted nodes: poor prognostic marker in oropharyngeal squamous cell carcinoma independent of HPV and EGFR status.
    Head & neck, 2012, Volume: 34, Issue:12

    Topics: Bromhexine; Carcinoma, Squamous Cell; ErbB Receptors; Female; Head and Neck Neoplasms; Humans; Lymph

2012